drugset
drugset / Trial / NCT06502379

A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants

NCT06502379 ↗

Phase 1 Completed 147 enrolled AstraZeneca
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) of AZD8965 via single and multiple ascending doses in healthy participants (including Japanese and Chinese participants), and to assess the effect of food on the safety, tolerability, and PK of orally administered AZD8965.

Timeline

Start
2024-08-02
Primary completion
2025-06-01
Completion
2025-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8965 Unknown — Oral

Indications

No indication recorded.